rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
7	Neoplasm of the oral cavity	C0026640	6	226	5.34574606803e-11	6.369426751592357e-06	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
8	Retinoblastoma	C0035335	8	473	5.66384716905e-11	7.279344858962693e-06	CDKN1A,E2F1,CDK6,TFDP2,CCND1,CDKN1B,PRMT5,CDK4
9	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	C0334634	7	327	8.45843395325e-11	8.18926296633303e-06	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
11	Non-Hodgkin lymphoma	C0024305	7	556	1.03753561298e-10	1.0009099181073704e-05	CDKN1A,E2F1,TFDP1,CCND1,CDKN1B,PRMT5,CDK4
12	Neoplasm of the parathyroid gland	C0030521	4	59	1.43796419216e-10	1.0919017288444041e-05	CDKN1A,E2F1,CCND1,CDKN1B
13	Atypical nevus	C0205748	4	65	1.52468926373e-10	1.1828935395814377e-05	CDKN1A,CDK6,CCND1,CDK4
15	Multiple Endocrine Neoplasia Type 1	C0025267	4	81	3.68922115079e-10	1.364877161055505e-05	CDKN1A,CCND1,CDKN1B,CDK4
16	Intraocular melanoma	C0220633	5	206	4.11335188133e-10	1.4558689717925387e-05	E2F1,CDK6,CCND1,CDKN1B,CDK4
18	Prolactinoma, familial	C0033375	4	95	8.18188405916e-10	1.637852593266606e-05	CDKN1A,E2F1,CCND1,CDKN1B
19	Precancerous Conditions	C0032927	6	455	8.82184436612e-10	1.7288444040036397e-05	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
25	Adenocarcinoma of lung	C0152013	7	815	1.19011711597e-09	2.2747952684258417e-05	WDR77,CDKN1A,E2F1,CCND1,CDKN1B,PRMT5,CDK4
26	Neuroendocrine neoplasm	C0206754	5	252	1.4122797376e-09	2.3657870791628753e-05	CDKN1A,CDK6,CCND1,CDKN1B,CDK4
27	Bisphosphonate-associated osteonecrosis	C2986536	3	34	1.84191750741e-09	2.4567788898999092e-05	CDKN1A,CCND1,CDK4
28	Pituitary adenoma	C0032000	5	286	2.98621061212e-09	2.5477707006369428e-05	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
33	Angiofibromas	C0206731	3	42	4.45007264371e-09	3.002729754322111e-05	CDKN1A,CDKN1B,CDK4
34	Testicular Neoplasms	C0039590	4	139	5.51509271585e-09	3.0937215650591445e-05	WDR77,CDKN1B,PRMT5,CDK4
35	Lung cancer	C0684249	9	2234	5.66240299094e-09	3.184713375796179e-05	WDR77,CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
39	Pituitary corticotropic cell adenoma	C1306214	3	45	5.9439063671e-09	3.5486806187443136e-05	CDKN1A,CCND1,CDKN1B
40	Intestinal Neoplasms	C0021841	4	145	6.7475165455e-09	3.6396724294813465e-05	CDKN1A,CCND1,CDKN1B,CDK4
41	Lipomatous tumor	C0206631	3	48	7.71003727529e-09	3.73066424021838e-05	CDKN1A,CDKN1B,CDK4
42	Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation	C0751690	4	151	8.29894253318e-09	3.8216560509554137e-05	CCND1,CDKN1B,COPRS,CDK4
43	Gastrointestinal stromal tumor	C0238198	5	340	8.33921764976e-09	3.912647861692448e-05	CDKN1A,E2F1,CDK6,CCND1,CDK4
47	B-cell lymphoma	C0079731	6	652	1.01604215041e-08	4.276615104640583e-05	CDKN1A,CDK6,CCND1,CDKN1B,PRMT5,CDK4
48	Leukemogenesis	C0598766	6	660	1.09996264319e-08	4.3676069153776164e-05	CDKN1A,E2F1,CCND1,CDKN1B,PRMT5,CDK4
49	Hematopoietic Neoplasms	C0376544	4	168	1.41998216519e-08	4.458598726114649e-05	CDK6,CCND1,CDKN1B,CDK4
50	Malignant neoplasm of lung	C0242379	9	2460	1.44116987233e-08	4.5495905368516835e-05	WDR77,CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
51	Uterine Cervical Neoplasms	C0007873	4	171	1.54666606189e-08	4.640582347588717e-05	CDKN1A,E2F1,CCND1,CDKN1B
52	Human papilloma virus infection	C0343641	3	57	1.56120200101e-08	4.7315741583257506e-05	CDKN1A,CCND1,CDKN1B
53	Mesothelioma, malignant	C0025500	5	383	1.69588942889e-08	4.822565969062784e-05	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
54	Chronic Lymphocytic Leukemia	C0023434	7	1176	2.03269100441e-08	4.9135577797998184e-05	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
57	Fibrosis	C0016059	4	191	2.69669070407e-08	5.18653321201092e-05	CDKN1A,CCND1,CDKN1B,CDK4
59	Hyperparathyroidism 4	C0020502	3	68	3.20383801711e-08	5.368516833484986e-05	CDKN1A,CCND1,CDKN1B
61	Neoplasm of the skin	C0037286	5	438	3.760485634e-08	5.550500454959054e-05	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
62	Mammary Neoplasms, Experimental	C0024668	4	207	4.02397829502e-08	5.6414922656960876e-05	CDK6,CCND1,CDKN1B,CDK4
63	Neoplasm of the adrenal cortex	C0001618	3	74	4.51283067582e-08	5.732484076433121e-05	CDKN1A,CDKN1B,CDK4
66	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	8	1967	4.93122555012e-08	6.005459508644222e-05	CDKN1A,E2F1,TFDP1,CDK6,TFDP2,CCND1,CDKN1B,CDK4
67	Urinary Bladder Neoplasms	C0005695	5	463	5.22706944395e-08	6.0964513193812554e-05	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
68	Sarcoma, Ewing	C1261473	6	829	5.2673145845e-08	6.187443130118289e-05	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
69	Uterine neoplasm	C0042138	3	77	5.3031832925e-08	6.278434940855324e-05	CDKN1A,CCND1,CDKN1B
70	Epithelial hyperplasia of skin	C0014599	3	78	5.59111897891e-08	6.369426751592357e-05	E2F1,CCND1,CDK4
71	Abnormal concentration of calcium in blood	C0004268	3	78	5.59111897891e-08	6.46041856232939e-05	CDKN1A,CCND1,CDKN1B
73	Lymphoma, Large B-Cell, Diffuse	C0024299	7	1362	6.36900717721e-08	6.642402183803457e-05	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
74	Chromosome Aberrations	C0008625	3	81	6.50481147835e-08	6.733393994540492e-05	CDKN1A,CDK6,CCND1
77	Thyroid Neoplasms	C0040136	5	486	6.9589777496e-08	7.006369426751592e-05	CDKN1A,E2F1,CDK6,CCND1,CDKN1B
78	Soft Tissue Neoplasms	C0037579	3	86	8.29427950766e-08	7.097361237488627e-05	CDKN1A,CCND1,CDK4
81	Malignant tumor of cervix	C0007847	6	889	8.49746181197e-08	7.370336669699728e-05	CDKN1A,E2F1,TFDP2,CCND1,CDKN1B,CDK4
82	Vestibular Schwannoma	C0027859	3	89	9.52776939567e-08	7.46132848043676e-05	CDKN1A,CCND1,CDKN1B
83	Thyroid adenoma	C0151468	3	89	9.52776939567e-08	7.552320291173795e-05	CDKN1A,E2F1,CDKN1B
84	Stomach Neoplasms	C0038356	6	916	1.04299908155e-07	7.643312101910827e-05	CDKN1A,E2F1,CCND1,CDKN1B,PRMT5,CDK4
85	Parathyroid adenoma	C0262587	3	93	1.13833364179e-07	7.734303912647862e-05	CDKN1A,CCND1,CDKN1B
86	Follicular adenoma	C0205647	3	94	1.18803269888e-07	7.825295723384896e-05	CDKN1A,E2F1,CCND1
87	Osteosarcoma	C0585442	6	936	1.2078484779e-07	7.91628753412193e-05	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
88	Ovarian Neoplasms	C0919267	6	942	1.262028827e-07	8.007279344858963e-05	WDR77,CDKN1A,E2F1,CCND1,CDKN1B,CDK4
89	Anaplastic large cell lymphoma, ALK negative	C0206180	4	263	1.32507320338e-07	8.098271155595996e-05	CDKN1A,CDK6,CCND1,CDKN1B
90	Cutaneous malignant melanoma 3	C0151779	4	264	1.35046499317e-07	8.18926296633303e-05	E2F1,CDK6,CCND1,CDK4
93	Malignant mesothelioma	C0345967	4	266	1.40188392006e-07	8.462238398544131e-05	CDKN1A,CCND1,CDKN1B,CDK4
96	Neoplasm Recurrence, Local	C0027643	4	277	1.71488450662e-07	8.735213830755233e-05	CDKN1A,CCND1,CDKN1B,CDK4
97	Pancreatic Ductal Adenocarcinoma	C1335302	5	567	1.72822699929e-07	8.826205641492266e-05	CDKN1A,E2F1,CDK6,CCND1,CDK4
98	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	5	568	1.74593999369e-07	8.917197452229299e-05	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
99	Hamartoma	C0018552	3	106	1.92901577711e-07	9.008189262966333e-05	CDKN1A,CCND1,CDKN1B
100	polyps	C0032584	4	284	1.94070341464e-07	9.099181073703367e-05	CDKN1A,E2F1,CCND1,CDK4
102	Abnormality of calcium homeostasis	C4025337	3	108	2.07963596566e-07	9.281164695177434e-05	CDKN1A,CCND1,CDKN1B
103	Skin Carcinogenesis	C1519346	3	110	2.23855616155e-07	9.372156505914469e-05	CDK6,CCND1,CDK4
104	Neoplasm of the anterior pituitary	C4023205	2	25	2.33763449931e-07	9.463148316651501e-05	CDKN1A,CDKN1B
105	Fibromyxosarcoma	C3714524	2	25	2.33763449931e-07	9.554140127388536e-05	CCND1,CDKN1B
110	Adenocarcinoma Of Esophagus	C0279628	4	300	2.54665851518e-07	0.00010009099181073704	CDKN1A,CDK6,CCND1,CDK4
111	Carcinoma of cervix	C0302592	6	1045	2.55859276987e-07	0.00010100090991810738	CDKN1A,E2F1,TFDP2,CCND1,CDKN1B,CDK4
112	Hypercalcemia, infantile, 2	C0020437	3	114	2.58442216516e-07	0.00010191082802547771	CDKN1A,CCND1,CDKN1B
113	Abnormality of divalent inorganic cation homeostasis	C4023648	3	115	2.67696006917e-07	0.00010282074613284805	CDKN1A,CCND1,CDKN1B
114	Abnormality of endocrine pancreas physiology	C4023047	2	27	2.97083763368e-07	0.0001037306642402184	CDKN1A,CDKN1B
115	Liposarcoma, Dedifferentiated	C0205824	2	28	3.32603994679e-07	0.00010464058234758872	CCND1,CDK4
116	Astrocytoma, low grade	C1314694	2	28	3.32603994679e-07	0.00010555050045495905	CDKN1A,CDKN1B
117	Abnormality of subcutaneous fat tissue	C4025813	2	28	3.32603994679e-07	0.00010646041856232939	CDKN1A,CDKN1B
118	Abnormality of circulating glucocorticoid level	C4023038	2	28	3.32603994679e-07	0.00010737033666969972	CDKN1A,CDKN1B
119	Abnormality of circulating cortisol level	C4023214	2	28	3.32603994679e-07	0.00010828025477707007	CDKN1A,CDKN1B
120	Bladder carcinoma	C0699885	6	1087	3.34376493605e-07	0.0001091901728844404	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
121	Peripheral T-Cell Lymphoma	C0079774	3	122	3.39447689512e-07	0.00011010009099181075	CDK6,CCND1,CDKN1B
122	Cancer Cell Growth	C1516170	4	320	3.50521133452e-07	0.00011101000909918108	CDKN1A,CCND1,CDKN1B,CDK4
123	Peptic ulcer	C0030920	3	123	3.50754900014e-07	0.00011191992720655142	CDKN1A,CCND1,CDKN1B
124	Alzheimer Disease	C0002395	7	1699	3.52290264849e-07	0.00011282984531392175	CDKN1A,E2F1,TFDP1,CCND1,CDKN1B,PRMT5,CDK4
125	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	7	1700	3.539270923e-07	0.00011373976342129207	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
126	Pituitary Neoplasms	C0032019	4	321	3.55989139611e-07	0.00011464968152866242	CDKN1A,E2F1,CCND1,CDKN1B
127	Abnormality of the pituitary gland	C0032002	5	645	3.68648892746e-07	0.00011555959963603276	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
128	Extrahepatic cholestasis	C0005398	2	30	4.11934712341e-07	0.0001164695177434031	CDKN1A,CDKN1B
129	Head and Neck Neoplasms	C0018671	4	333	4.2677838108e-07	0.00011737943585077343	CDKN1A,CCND1,CDKN1B,CDK4
130	Brain neoplasm	C0006118	5	667	4.48829671873e-07	0.00011828935395814378	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
131	Adrenal overactivity	C4025685	2	31	4.5591348341e-07	0.0001191992720655141	CDKN1A,CDKN1B
132	Neoplasm of the thymus	C3714644	2	31	4.5591348341e-07	0.00012010919017288444	CDKN1A,CDKN1B
133	Astrocytoma	C0004114	5	674	4.77108326624e-07	0.00012101910828025479	CDKN1A,CCND1,CDKN1B,PRMT5,CDK4
134	Lung Neoplasms	C0024121	6	1155	5.04525517364e-07	0.00012192902638762511	CDKN1A,E2F1,TFDP1,CCND1,CDKN1B,CDK4
135	Leiomyosarcoma	C0023269	3	136	5.2475258272e-07	0.00012283894449499546	E2F1,CCND1,CDK4
136	keratoacanthoma	C0022572	2	34	6.06380526014e-07	0.00012374886260236578	CDKN1A,CCND1
137	Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	C3536893	2	35	6.63103994269e-07	0.00012465878070973613	CCND1,CDK4
138	Squamous cell carcinoma	C0007137	7	1855	6.92190098128e-07	0.00012556869881710648	CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,CDK4
139	Invasive breast carcinoma	C0853879	4	369	7.083766973e-07	0.0001264786169244768	CDKN1A,CDK6,CCND1,CDKN1B
150	Neoplasm of the peripheral nervous system	C0031118	2	36	7.23134487957e-07	0.0001364877161055505	CDKN1A,CDKN1B
151	T-cell acute lymphoblastic leukemias	C1961099	4	371	7.27515909293e-07	0.00013739763421292085	CDKN1A,CCND1,CDKN1B,CDK4
152	Carcinogenesis	C0596263	9	3723	7.83258172765e-07	0.00013830755232029118	WDR77,CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
153	Multiple lipomas	C0745730	2	37	7.86740774639e-07	0.0001392174704276615	CDKN1A,CDKN1B
154	Multiple Myeloma	C0026764	6	1236	7.97896482219e-07	0.00014012738853503185	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
155	Parathyroid carcinoma	C0687150	2	38	8.53874924656e-07	0.0001410373066424022	CCND1,CDKN1B
156	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	7	1913	8.76459467336e-07	0.00014194722474977255	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
157	Leukemia, Lymphocytic, Acute, L1	C0023452	4	388	9.0720839363e-07	0.00014285714285714284	CDKN1A,CCND1,CDKN1B,CDK4
158	androgen independent prostate cancer	C1654637	3	156	9.08568660307e-07	0.0001437670609645132	CDKN1A,CCND1,CDKN1B
159	Intracranial glioma	C3665419	2	39	9.24806326186e-07	0.00014467697907188354	CDKN1A,CDK4
160	Urothelial Carcinoma	C0007138	4	391	9.42212497468e-07	0.00014558689717925386	CDKN1A,E2F1,CCND1,CDKN1B
161	Familial adenomatous polyposis 1	C0032580	4	395	9.90675955936e-07	0.0001464968152866242	CDKN1A,TFDP1,CCND1,CDK4
162	Abnormality of the thymus	C0262650	2	40	9.9943097176e-07	0.00014740673339399456	CDKN1A,CDKN1B
163	Bronchogenic Carcinoma	C0007121	2	41	1.07807388783e-06	0.00014831665150136488	CDKN1A,E2F1
164	Gastrointestinal inflammation	C1535950	2	41	1.07807388783e-06	0.0001492265696087352	CDKN1A,CDKN1B
165	Cancer of the lower GI tract	C0006826	4	403	1.09335563359e-06	0.00015013648771610555	CDKN1A,E2F1,CCND1,CDKN1B
166	Carcinosarcoma	C0007140	2	42	1.16060245281e-06	0.0001510464058234759	CCND1,CDK4
167	Non-small cell lung carcinoma	C0007131	7	1993	1.19917382979e-06	0.00015195632393084625	CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,CDK4
168	Glioma	C0017638	7	1997	1.21770038064e-06	0.00015286624203821655	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
169	Malignant Glioma	C0555198	4	412	1.21875768488e-06	0.0001537761601455869	E2F1,CCND1,CDKN1B,CDK4
170	Chloracne	C0263454	2	43	1.24731090378e-06	0.00015468607825295724	CDK6,CDKN1B
171	Malignant neoplasm of male breast	C0242787	2	43	1.24731090378e-06	0.00015559599636032757	CCND1,CDKN1B
172	Lip and Oral Cavity Carcinoma	C0220641	4	419	1.32403041098e-06	0.00015650591446769792	CDKN1A,CCND1,CDKN1B,CDK4
173	Cancer of mouth	C0153381	4	420	1.33959227477e-06	0.00015741583257506826	CDKN1A,CCND1,CDKN1B,CDK4
174	Benign Prostatic Hyperplasia	C1704272	4	423	1.38728497079e-06	0.0001583257506824386	WDR77,CCND1,CDKN1B,CDK4
175	Nevus	C0497388	3	174	1.40466366039e-06	0.0001592356687898089	CDK6,CCND1,CDK4
189	Hyperoxia	C0242706	2	45	1.43334409552e-06	0.00017197452229299363	CDKN1A,CDK4
190	Fibrous tissue neoplasm	C0206643	2	45	1.43334409552e-06	0.00017288444040036396	CDKN1A,CDKN1B
191	Hereditary cutaneous melanoma	C1512419	2	45	1.43334409552e-06	0.0001737943585077343	CDK6,CDK4
192	Abnormality of the lymphatic system	C4021976	4	426	1.4363045987e-06	0.00017470427661510466	CDKN1A,CCND1,CDKN1B,CDK4
193	Thymoma	C0040100	3	176	1.47008180151e-06	0.00017561419472247498	CDKN1A,CCND1,CDKN1B
194	Cancer of Head and Neck	C0278996	4	430	1.50369964247e-06	0.00017652411282984533	CDKN1A,CDK6,CCND1,CDKN1B
195	Chronic myeloid leukemia	C0023473	5	822	1.52142470966e-06	0.00017743403093721568	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
196	Neoplasm of fatty tissue	C4021901	2	46	1.53289013316e-06	0.00017834394904458597	CDKN1A,CDKN1B
197	Synovial sarcoma	C0039101	3	178	1.53776830203e-06	0.00017925386715195632	CDKN1A,CCND1,CDKN1B
198	Acute lymphoid leukemia	C0023449	5	824	1.54309277045e-06	0.00018016378525932667	CDKN1A,CDK6,CCND1,CDKN1B,CDK4
199	Glioblastoma multiforme	C1621958	4	434	1.57370012754e-06	0.00018107370336669702	E2F1,CDK6,PRMT5,CDK4
200	Malignant tumor of urinary bladder	C0005684	6	1371	1.60415892458e-06	0.00018198362147406734	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
201	Embryonal Carcinoma	C0206659	3	181	1.64364424826e-06	0.00018289353958143766	CCND1,CDKN1B,CDK4
202	Bile duct cancer resectable	C0740277	2	48	1.74550740961e-06	0.000183803457688808	CCND1,CDKN1B
203	Kaposi's sarcoma	C0036220	3	184	1.75489380161e-06	0.00018471337579617833	CDK6,CCND1,CDKN1B
204	Melanocytic nevus	C0027962	3	185	1.79310485238e-06	0.00018562329390354868	CDKN1A,CDK6,CCND1
205	Splenic Marginal Zone B-Cell Lymphoma	C0349632	2	49	1.85880169767e-06	0.00018653321201091903	CDK6,CCND1
206	Spinal muscular atrophy with congenital bone fractures 2	C0026847	3	187	1.87155925591e-06	0.00018744313011828938	WDR77,CDKN1A,PRMT5
207	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	5	854	1.89983460741e-06	0.00018835304822565968	CDKN1A,CDK6,CCND1,CDKN1B,CDK4
208	Abnormality of cation homeostasis	C4023646	3	192	2.07868581525e-06	0.00018926296633303002	CDKN1A,CCND1,CDKN1B
209	Malignant neoplasm of female breast	C0235653	2	51	2.09983744737e-06	0.00019017288444040037	CCND1,CDKN1B
210	Non-Neoplastic Disorder	C1709246	4	461	2.11576513121e-06	0.00019108280254777072	CDKN1A,E2F1,CCND1,CDKN1B
211	Neoplasm by histology	C4023186	3	193	2.12215072115e-06	0.00019199272065514105	CDKN1A,CDKN1B,CDK4
212	Acute Erythroblastic Leukemia	C0023440	3	195	2.21092853026e-06	0.00019290263876251137	CDKN1A,E2F1,CCND1
213	Papilloma	C0030354	3	196	2.25630474171e-06	0.00019381255686988172	CDKN1A,CCND1,CDK4
214	Functional abnormality of the gastrointestinal tract	C4022755	4	470	2.32596294425e-06	0.00019472247497725204	CDKN1A,CCND1,CDKN1B,CDK4
215	Hepatocarcinogenesis	C1512409	4	471	2.350281188e-06	0.0001956323930846224	CDKN1A,E2F1,CCND1,CDKN1B
216	Primary hyperparathyroidism	C0221002	2	53	2.36071869497e-06	0.00019654231119199274	CCND1,CDKN1B
230	Esophageal Squamous Cell Carcinoma	C0279626	5	888	2.38332799352e-06	0.00020928116469517744	CDKN1A,E2F1,CDK6,CCND1,CDK4
231	Medullary thyroid carcinoma	C0238462	3	201	2.49393836715e-06	0.00021019108280254778	E2F1,CCND1,CDKN1B
232	Fibroma	C0016045	2	54	2.49878608338e-06	0.0002111010009099181	CDKN1A,CDKN1B
233	Female Breast Carcinoma	C0007104	2	54	2.49878608338e-06	0.00021201091901728846	CCND1,CDKN1B
234	Hepatocellular carcinoma	C2239176	8	3108	2.5559365322e-06	0.00021292083712465878	CDKN1A,E2F1,TFDP1,CDK6,TFDP2,CCND1,CDKN1B,CDK4
235	Carcinoma of Male Breast	C0238033	2	55	2.64223406321e-06	0.00021383075523202913	CCND1,CDKN1B
236	Carcinoma, Neuroendocrine	C0206695	2	55	2.64223406321e-06	0.00021474067333939945	CDKN1A,CDKN1B
237	Multiple endocrine neoplasia, type 4	C0027662	2	56	2.79092973343e-06	0.0002156505914467698	CCND1,CDKN1B
238	Medullary carcinoma	C0206693	2	57	2.94514058718e-06	0.00021656050955414015	CDK6,CCND1
239	Abnormality of the parathyroid physiology	C4023198	2	57	2.94514058718e-06	0.00021747042766151044	CDKN1A,CDKN1B
240	Ataxia-telangiectasia syndrome	C0004135	3	212	3.0815699148e-06	0.0002183803457688808	CDKN1A,E2F1,CCND1
241	Abnormality of the pancreas	C4025751	3	212	3.0815699148e-06	0.00021929026387625114	CDKN1A,CDKN1B,CDK4
242	Neoplasms, Experimental	C0027659	2	58	3.10484107402e-06	0.0002202001819836215	CCND1,CDK4
243	Abnormality of ion homeostasis	C4025654	3	214	3.19856195774e-06	0.0002211101000909918	CDKN1A,CCND1,CDKN1B
244	Malignant neoplasm of endometrium	C0007103	4	506	3.33732421043e-06	0.00022202001819836216	CDKN1A,CCND1,CDKN1B,CDK4
245	Uterine Corpus Cancer	C0153574	4	506	3.33732421043e-06	0.00022292993630573248	CDKN1A,CCND1,CDKN1B,CDK4
246	Oropharyngeal Carcinoma	C2349952	2	60	3.44133349461e-06	0.00022383985441310283	E2F1,CCND1
251	Skin cancer	C0007114	3	222	3.699715448e-06	0.0002283894449499545	CDKN1A,CCND1,CDK4
252	Testicular seminoma	C0036631	3	222	3.699715448e-06	0.00022929936305732485	WDR77,CDK6,PRMT5
253	Chondrosarcoma	C0008479	3	222	3.699715448e-06	0.0002302092811646952	CDKN1A,CCND1,CDK4
254	Intraosseous mucoepidermoid carcinoma	C0206694	2	62	3.80112520548e-06	0.00023111919927206552	CCND1,CDK4
255	Esophagitis	C0014868	2	62	3.80112520548e-06	0.00023202911737943587	CDKN1A,CDKN1B
256	Vitreoretinopathy, neovascular inflammatory, 193235 (3)	C0242852	2	63	3.99004568896e-06	0.0002329390354868062	CDKN1A,CCND1
257	Early-Stage Breast Carcinoma	C2986665	2	64	4.18499855814e-06	0.0002338489535941765	CCND1,CDKN1B
258	Abnormality of the parathyroid gland	C4025822	2	64	4.18499855814e-06	0.00023475887170154686	CDKN1A,CDKN1B
259	Hyperpituitarism	C0020506	2	64	4.18499855814e-06	0.0002356687898089172	CDKN1A,CDKN1B
260	Breast Fibrocystic Disease	C0016034	2	64	4.18499855814e-06	0.00023657870791628756	CCND1,CDKN1B
261	Rhabdoid tumors, somatic, 609322 (3)	C0206743	2	64	4.18499855814e-06	0.00023748862602365785	CDKN1A,CCND1
262	Anaplasia	C0002793	3	231	4.33071094885e-06	0.0002383985441310282	CCND1,CDKN1B,CDK4
263	Carcinoma, Papillary	C0007133	3	233	4.48115673968e-06	0.00023930846223839855	TFDP2,CCND1,CDKN1B
264	Prostatic Neoplasms	C0033578	6	1606	4.62629375875e-06	0.00024021838034576887	WDR77,CDKN1A,E2F1,CDK6,CCND1,CDKN1B
265	Medulloblastoma	C0025149	4	543	4.70964947852e-06	0.00024112829845313922	E2F1,CDK6,CCND1,CDKN1B
266	Lymphoproliferative disorder	C0024314	3	236	4.71398932411e-06	0.00024203821656050957	CDK6,CCND1,CDKN1B
267	Neuroblastoma	C0700095	6	1612	4.7427681219e-06	0.0002429481346678799	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
277	Malignant neoplasm of pancreas	C0346647	6	1625	5.00349172816e-06	0.00025204731574158325	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
278	Abnormality of adrenal morphology	C4023213	2	68	5.02811430914e-06	0.0002529572338489536	CDKN1A,CDKN1B
279	Adenocarcinoma of colon	C0338106	3	240	5.03828111653e-06	0.00025386715195632395	CDKN1A,CCND1,CDKN1B
280	Xenograft Model	C1520166	4	551	5.05765471137e-06	0.0002547770700636943	CDKN1A,E2F1,CCND1,CDKN1B
281	Malignant neoplasm of colon stage IV	C0278484	2	69	5.25509019755e-06	0.0002556869881710646	E2F1,CCND1
282	Glioblastoma	C0017636	6	1645	5.42817656202e-06	0.00025659690627843494	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
283	Neoplasm by anatomical site	C4023185	4	576	6.27733634251e-06	0.0002575068243858053	CDKN1A,CCND1,CDKN1B,CDK4
284	Fibrosarcoma	C0016057	3	254	6.30453996653e-06	0.0002584167424931756	E2F1,CCND1,CDK4
285	Cutaneous T-cell lymphoma	C0079773	3	255	6.40320141487e-06	0.00025932666060054594	E2F1,CCND1,CDKN1B
286	Breast Cancer Model	C1511291	2	74	6.49227700245e-06	0.0002602365787079163	CCND1,CDK4
287	Pancreatic Carcinoma	C0235974	6	1690	6.49555393517e-06	0.00026114649681528663	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
293	Microphthalmia syndromic 6	C0026010	3	258	6.7060343284e-06	0.0002666060054595086	E2F1,CDKN1B,CDK4
294	Oral leukoplakia	C0023532	2	75	6.76079090656e-06	0.00026751592356687897	CCND1,CDKN1B
295	Esophageal carcinoma	C0152018	4	585	6.76899703189e-06	0.0002684258416742493	CDKN1A,E2F1,CCND1,CDKN1B
296	Pheochromocytoma	C0031511	3	259	6.80932992869e-06	0.00026933575978161967	E2F1,CCND1,CDKN1B
297	Paragangliomas 1	C0030421	2	76	7.03652943135e-06	0.00027024567788899	CCND1,CDKN1B
298	Colon cancer	C0007102	6	1727	7.50049754272e-06	0.00027115559599636037	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
299	Colorectal cancer 1	C0009402	7	2543	7.62247293473e-06	0.00027206551410373066	CDKN1A,E2F1,TFDP1,TFDP2,CCND1,CDKN1B,CDK4
300	Acute myeloid leukemia	C0023467	6	1733	7.67518331879e-06	0.000272975432211101	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
301	Endometrial Neoplasms	C0014170	3	268	7.79259586969e-06	0.00027388535031847136	CDKN1A,CDK6,CCND1
302	Gastrointestinal Neoplasms	C0017185	3	268	7.79259586969e-06	0.0002747952684258417	CDKN1A,CDKN1B,CDK4
303	Scar conditions and fibrosis of skin	C0241158	2	79	7.90829887298e-06	0.000275705186533212	CDKN1A,CCND1
304	Benign melanocytic nevus	C1456781	2	80	8.21398160256e-06	0.00027661510464058235	CDK6,CCND1
305	Hepatic cancer metastatic	C0345904	4	613	8.49517536761e-06	0.0002775250227479527	CDKN1A,E2F1,CCND1,CDK4
306	Increased analgesia from kappa-opioid receptor agonist, female-specific	C0205217	2	81	8.52740832658e-06	0.000278434940855323	CDKN1A,CDKN1B
313	Undifferentiated carcinoma	C0205698	2	83	9.17786594867e-06	0.0002848043676069154	CDKN1A,CCND1
314	Lichen Planus, Oral	C0206139	2	83	9.17786594867e-06	0.0002857142857142857	CDKN1A,CCND1
315	Alveolar rhabdomyosarcoma	C0206655	2	84	9.51490496159e-06	0.00028662420382165603	E2F1,CDK4
316	Abnormality of the urinary system	C4021821	5	1136	9.87584064538e-06	0.0002875341219290264	CDKN1A,CDK6,CCND1,CDKN1B,CDK4
317	Rectal Carcinoma	C0149978	3	286	1.00695324547e-05	0.00028844404003639673	CDKN1A,CCND1,CDKN1B
318	Alveolar cell carcinoma	C0007120	2	86	1.02135392614e-05	0.0002893539581437671	CCND1,CDKN1B
319	Mucinous Adenocarcinoma	C0007130	2	86	1.02135392614e-05	0.00029026387625113743	CDKN1A,CDKN1B
320	Liver regeneration disorder	C1318485	2	87	1.05752074308e-05	0.0002911737943585077	CDKN1A,CCND1
330	Noninfiltrating Intraductal Carcinoma	C0007124	3	291	1.07811009705e-05	0.0003002729754322111	CDKN1A,CCND1,CDKN1B
331	Neoplasms	C0027651	4	646	1.09547391476e-05	0.00030118289353958145	CDKN1A,CCND1,CDKN1B,CDK4
332	Plasmacytoma	C0032131	2	89	1.13237215137e-05	0.0003020928116469518	CCND1,CDK4
333	Adrenocortical adenoma	C0206667	2	89	1.13237215137e-05	0.00030300272975432215	CDKN1A,CDKN1B
334	Colorectal cancer	C1527249	7	2681	1.1338813894e-05	0.0003039126478616925	CDKN1A,E2F1,TFDP1,TFDP2,CCND1,CDKN1B,CDK4
335	Abnormality of the urinary system physiology	C4023437	4	654	1.1627625672e-05	0.0003048225659690628	CDKN1A,CCND1,CDKN1B,CDK4
336	Thyroid carcinoma	C0549473	4	659	1.20643634691e-05	0.0003057324840764331	CDKN1A,CCND1,CDKN1B,CDK4
337	Carcinoma of colon	C0699790	6	1856	1.208611265e-05	0.00030664240218380344	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
338	Actinic keratosis	C0022602	2	91	1.21064006375e-05	0.0003075523202911738	CDKN1A,CDK4
339	DNA Damage	C0012860	2	91	1.21064006375e-05	0.00030846223839854414	CDKN1A,CCND1
340	T-cell lymphoma	C0079772	3	302	1.24765289594e-05	0.0003093721565059145	CDK6,CCND1,CDK4
341	Dementia familial British	C0011265	3	302	1.24765289594e-05	0.00031028207461328484	CDKN1A,E2F1,CDKN1B
342	Reperfusion Injury	C0035126	3	305	1.29712634021e-05	0.00031119199272065513	CDKN1A,CCND1,CDKN1B
345	Prostate carcinoma	C0600139	7	2734	1.31305591262e-05	0.0003139217470427662	WDR77,CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
346	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	4	671	1.31652079841e-05	0.00031483166515013653	CDKN1A,E2F1,CCND1,CDK4
347	Esophageal Neoplasms	C0014859	4	686	1.46504285593e-05	0.0003157415832575068	CDKN1A,E2F1,CCND1,CDKN1B
348	Leiomyoma	C0023267	3	316	1.49099932483e-05	0.0003166515013648772	CDKN1A,CCND1,CDKN1B
349	Macule	C0332573	2	98	1.5125833162e-05	0.00031756141947224747	CDKN1A,CDKN1B
355	Huntington's chorea	C0020179	3	320	1.56654239272e-05	0.00032302092811646956	E2F1,CCND1,CDKN1B
356	Leukemia, B-Cell	C2004493	2	100	1.60714671951e-05	0.00032393084622383986	CDKN1A,CCND1
357	Advanced cancer	C0877373	2	100	1.60714671951e-05	0.0003248407643312102	E2F1,CCND1
358	Testicular Germ Cell Tumor	C1336708	2	103	1.75619148327e-05	0.0003257506824385805	CDKN1A,CCND1
359	Endometrial adenocarcinoma	C1153706	2	103	1.75619148327e-05	0.00032666060054595085	CDKN1A,CCND1
360	Tumor Progression	C0178874	6	1969	1.78459827157e-05	0.0003275705186533212	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
367	Neoplasm of the larynx	C0023055	2	106	1.91407961434e-05	0.0003339399454049136	CDKN1A,CCND1
368	precancerous lesions	C0940937	2	106	1.91407961434e-05	0.00033484986351228394	CDKN1A,CDKN1B
369	Endometrial carcinoma	C0476089	4	726	1.92599272647e-05	0.00033575978161965424	CDKN1A,CCND1,CDKN1B,CDK4
370	Abnormality of thyroid morphology	C4023195	2	107	1.96871048537e-05	0.00033666969972702453	CDKN1A,CDKN1B
371	Carcinoma, Small Cell	C0262584	2	108	2.02436911528e-05	0.0003375796178343949	CCND1,CDKN1B
372	Neoplasm of the liver	C0023903	5	1290	2.04305255411e-05	0.00033848953594176523	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
373	Abnormality of skin pigmentation	C1260926	3	344	2.08062863869e-05	0.0003393994540491356	CDKN1A,CDKN1B,CDK4
374	Mixed Salivary Gland Tumor	C0026277	2	109	2.08104622206e-05	0.0003403093721565059	CCND1,CDK4
375	Intrahepatic Cholangiocarcinoma	C0345905	2	109	2.08104622206e-05	0.0003412192902638763	CDKN1A,CCND1
376	Hairy Cell Leukemia	C0023443	2	110	2.13876675812e-05	0.0003421292083712466	CCND1,CDKN1B
387	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	3	348	2.17707617604e-05	0.0003521383075523203	CDKN1A,CCND1,CDKN1B
388	Neoplasm of the endocrine system	C0014132	2	111	2.19753431731e-05	0.00035304822565969065	CDKN1A,CDKN1B
389	Neoplasm of the adrenal gland	C0001624	2	111	2.19753431731e-05	0.000353958143767061	CDKN1A,CDKN1B
390	Pancreatic Neoplasms	C0030297	4	750	2.25269825571e-05	0.00035486806187443135	CDKN1A,CCND1,CDKN1B,CDK4
391	Malignant tumor of prostate	C0376358	7	2940	2.25872739567e-05	0.00035577797998180165	WDR77,CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
392	Abnormality of adrenal physiology	C4023212	2	113	2.31824515428e-05	0.00035668789808917194	CDKN1A,CDKN1B
393	Abnormality of pancreas physiology	C4023048	2	115	2.44323213048e-05	0.0003575978161965423	CDKN1A,CDKN1B
394	Urinary tract neoplasm	C0042076	2	115	2.44323213048e-05	0.00035850773430391264	CCND1,CDKN1B
401	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	6	2073	2.50242982213e-05	0.00036487716105550503	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5
402	Renal neoplasm	C0022665	3	363	2.56831652957e-05	0.0003657870791628753	E2F1,CCND1,CDKN1B
403	Mammary Ductal Carcinoma	C0021367	2	117	2.57258530408e-05	0.0003666969972702457	E2F1,CCND1
404	Goiter, multinodular 1, with or without sertoli-leydig cell tumors	C0018021	2	118	2.63893260608e-05	0.000367606915377616	CCND1,CDKN1B
405	Xeroderma pigmentosum, group E	C0043346	2	119	2.70637743187e-05	0.00036851683348498637	CDKN1A,CDK4
406	Clear cell renal cell carcinoma	C0279702	3	368	2.70954598867e-05	0.00036942675159235667	E2F1,CCND1,CDKN1B
407	Squamous cell carcinoma of tongue	C0349566	2	120	2.7749677554e-05	0.000370336669699727	CCND1,CDKN1B
408	Stomach cancer	C0699791	6	2109	2.80122427743e-05	0.00037124658780709736	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,PRMT5
414	Primary Effusion Lymphoma	C1292753	2	121	2.84467578635e-05	0.00037670609645131935	CDK6,CDKN1B
415	Acute type B viral hepatitis	C0019163	4	790	2.89207874591e-05	0.0003776160145586897	CDKN1A,E2F1,CCND1,CDKN1B
416	Liposarcoma	C0023827	2	122	2.91553524688e-05	0.00037852593266606005	CCND1,CDK4
417	Abnormal insulin level	C4073160	2	123	2.98754657976e-05	0.0003794358507734304	CDKN1A,CDKN1B
418	Abnormal circulating insulin level	C4073161	2	123	2.98754657976e-05	0.00038034576888080075	CDKN1A,CDKN1B
419	Erythema	C0041834	2	123	2.98754657976e-05	0.0003812556869881711	CDKN1A,CDKN1B
426	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	3	385	3.23273388645e-05	0.00038762511373976343	CDK6,CCND1,CDKN1B
427	Ovarian epithelial cancer	C0677886	6	2172	3.39581733901e-05	0.0003885350318471338	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
428	Cervical Squamous Cell Carcinoma	C0279671	2	129	3.44431658903e-05	0.0003894449499545041	CCND1,CDKN1B
429	Congenital anomalies of kidney and urinary tract 1, susceptibility to	C0266292	4	820	3.4584463333e-05	0.0003903548680618744	CDK6,CCND1,CDKN1B,CDK4
430	Renal cell carcinoma, nonpapillary	C0007134	5	1418	3.49698635681e-05	0.0003912647861692448	CDKN1A,E2F1,CCND1,CDKN1B,CDK4
431	Squamous cell carcinoma of the head and neck	C1168401	4	825	3.56070302965e-05	0.0003921747042766151	CDKN1A,E2F1,CCND1,CDK4
432	Abnormality of the upper urinary tract	C4023641	4	827	3.60226306163e-05	0.0003930846223839855	CDK6,CCND1,CDKN1B,CDK4
437	Intraepithelial Neoplasia	C0878500	2	132	3.68897709819e-05	0.0003976342129208371	CDKN1A,CCND1
438	Elevated 7-dehydrocholesterol	C0205250	2	132	3.68897709819e-05	0.00039854413102820746	CDKN1A,CDKN1B
439	Breast carcinoma	C0678222	8	4281	3.78959619689e-05	0.0003994540491355778	CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
440	Laryngeal Squamous Cell Carcinoma	C0280324	2	134	3.85826523177e-05	0.00040036396724294816	CDKN1A,CCND1
441	Abnormality of the abdominal organs	C4021764	4	842	3.92616506988e-05	0.0004012738853503185	CDKN1A,CCND1,CDKN1B,CDK4
442	Asthma	C0004096	5	1454	4.03007820176e-05	0.0004021838034576888	CDKN1A,TFDP2,CCND1,CDKN1B,PRMT5
443	Liver Neoplasms, Experimental	C0023904	2	136	4.03259438901e-05	0.00040309372156505915	CDKN1A,CCND1
444	Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive	C0013575	2	136	4.03259438901e-05	0.0004040036396724295	CDKN1A,CCND1
451	Hodgkin Disease	C0019829	3	409	4.09320309018e-05	0.00041037306642402184	CDKN1A,CCND1,CDKN1B
452	Anaplastic astrocytoma	C0334579	2	137	4.12166757844e-05	0.0004112829845313922	CCND1,CDK4
453	Neoplasm of the nervous system	C0027766	2	139	4.30367454237e-05	0.00041219290263876254	CDKN1A,CDKN1B
454	Chronic obstructive pulmonary disease	C0024117	4	865	4.46649103248e-05	0.0004131028207461329	CDKN1A,CCND1,CDKN1B,CDK4
455	Mammary Tumorigenesis	C1512981	2	141	4.49088432773e-05	0.00041401273885350323	CCND1,CDKN1B
461	Prostatic Intraepithelial Neoplasias	C0282612	2	142	4.58646192379e-05	0.0004194722474977252	CCND1,CDKN1B
462	Hyperplasia	C0020507	2	143	4.68336852811e-05	0.00042038216560509557	CDKN1A,CCND1
463	Mycosis Fungoides	C0026948	2	143	4.68336852811e-05	0.0004212920837124659	E2F1,CCND1
464	Abnormality of adipose tissue	C4021524	2	144	4.78161550069e-05	0.0004222020018198362	CDKN1A,CDKN1B
471	Abnormality of the gastrointestinal tract	C4023588	4	886	5.00892069563e-05	0.00042857142857142855	CDKN1A,CCND1,CDKN1B,CDK4
472	invasive cancer	C0677898	2	150	5.39960161917e-05	0.0004294813466787989	CDKN1A,CCND1
477	Sezary Syndrome	C0036920	2	151	5.5074364136e-05	0.00043403093721565064	CCND1,CDKN1B
478	Tumor Angiogenesis	C1519670	3	443	5.58581917151e-05	0.0004349408553230209	CDKN1A,E2F1,CDK6
479	Animal Mammary Neoplasms	C0024667	6	2352	5.70245898214e-05	0.00043585077343039123	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
480	Invasive Carcinoma	C1334274	2	154	5.83940510855e-05	0.0004367606915377616	CCND1,CDKN1B
481	Abnormality of the genitourinary system	C0042063	5	1555	5.88642897227e-05	0.00043767060964513193	CDKN1A,CDK6,CCND1,CDKN1B,CDK4
482	Liver Cirrhosis, Biliary	C0023890	4	919	5.96359853974e-05	0.0004385805277525023	CDKN1A,E2F1,CCND1,CDK4
488	Papillary thyroid carcinoma	C0238463	3	451	5.98820484604e-05	0.0004440400363967243	CDKN1A,CCND1,CDKN1B
489	Meningioma	C0025286	3	452	6.03995717587e-05	0.00044494995450409467	CDKN1A,CCND1,CDK4
490	Thyroid cancer, nonmedullary, 4	C0007115	3	453	6.09203447934e-05	0.00044585987261146497	CDKN1A,CCND1,CDKN1B
491	Malignant neoplasm of brain and nervous system	C0153633	2	157	6.18423564657e-05	0.0004467697907188353	E2F1,CDK4
492	Insulinoma	C0021670	2	157	6.18423564657e-05	0.00044767970882620567	CDKN1A,CDKN1B
493	Primitive neuroectodermal tumor	C0206663	2	157	6.18423564657e-05	0.00044858962693357596	CCND1,CDK4
494	Breast-ovarian cancer, familial 1	C0006142	8	4543	6.19684987802e-05	0.0004494995450409463	CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,PRMT5,CDK4
495	Melanoma	C0025202	6	2386	6.2586372845e-05	0.00045040946314831666	CDKN1A,E2F1,CDK6,CCND1,CDKN1B,CDK4
496	Nonalcoholic Steatohepatitis	C3241937	2	158	6.30208605976e-05	0.000451319381255687	CDKN1A,E2F1
497	Monosomy	C0026499	2	158	6.30208605976e-05	0.00045222929936305736	CDKN1A,CCND1
498	Polycystic Kidney, Autosomal Dominant	C0085413	2	158	6.30208605976e-05	0.0004531392174704277	CDKN1A,CDK4
499	Triple Negative Breast Neoplasms	C3539878	3	461	6.52059223115e-05	0.00045404913557779806	E2F1,CDKN1B,CDK4
506	Adrenocortical carcinoma	C0206686	2	160	6.54217176771e-05	0.0004604185623293904	CDKN1A,CDKN1B
507	Abnormality of the adrenal glands	C4021794	2	161	6.66443395234e-05	0.0004613284804367607	CDKN1A,CDKN1B
508	Adult T-Cell Lymphoma/Leukemia	C0023493	3	469	6.97083505832e-05	0.00046223839854413103	CDKN1A,CCND1,CDKN1B
509	Mitochondrial Respiratory Chain Deficiencies	C0949857	1	25	7.09283977149e-05	0.0004631483166515014	CDKN1A
510	Isovaleryl-CoA dehydrogenase deficiency	C0268575	1	25	7.09283977149e-05	0.00046405823475887173	CCND1
511	Flushing	C0016382	1	25	7.09283977149e-05	0.0004649681528662421	TFDP1
512	Cutaneous lymphoma	C1276146	1	25	7.09283977149e-05	0.0004658780709736124	CCND1
513	Secondary hypertriglyceridemia	C0027627	7	3444	7.27385999071e-05	0.0004667879890809827	CDKN1A,E2F1,TFDP1,CDK6,CCND1,CDKN1B,CDK4
514	Down Syndrome	C0013080	3	476	7.38311873812e-05	0.000467697907188353	CDKN1A,CCND1,CDKN1B
515	Dementia	C0497327	3	477	7.44344537864e-05	0.00046860782529572337	CDKN1A,E2F1,CDKN1B
516	Lipomatosis, Multiple	C3489413	1	26	7.68170686319e-05	0.0004695177434030937	CDK4
517	Peritoneal Mesothelioma	C0346109	1	26	7.68170686319e-05	0.00047042766151046407	E2F1
518	Inappropriate ADH Syndrome	C1332347	1	26	7.68170686319e-05	0.0004713375796178344	CCND1
519	Sarcoma, Epithelioid	C0205944	1	26	7.68170686319e-05	0.00047224749772520477	CCND1
520	Oropharynx (excludes nasopharynx)	C0521367	1	26	7.68170686319e-05	0.0004731574158325751	CDKN1A
521	Plasmablastic lymphoma	C0079746	1	26	7.68170686319e-05	0.0004740673339399454	CDKN1B
522	Adenomas, multiple colorectal, 608456 (3)	C0001430	4	975	7.9019512368e-05	0.0004749772520473157	CDKN1A,CCND1,CDKN1B,CDK4
523	Disorders of parathyroid gland	C0030517	1	27	8.29386773801e-05	0.00047588717015468606	CCND1
524	Malignant lymphoma - lymphoplasmacytic	C0334633	1	27	8.29386773801e-05	0.0004767970882620564	CCND1
525	Gallbladder adenocarcinoma	C0279651	1	27	8.29386773801e-05	0.00047770700636942675	CCND1
526	Invasive Skin Melanoma	C1708565	1	27	8.29386773801e-05	0.0004786169244767971	CDK4
527	Combined Hepatocellular Carcinoma and Cholangiocarcinoma	C0221287	3	497	8.72727989096e-05	0.00047952684258416745	CDKN1A,E2F1,CCND1
528	Thyroid cancer, follicular	C0206682	2	177	8.8288558046e-05	0.00048043676069153775	E2F1,CDKN1B
529	Bovine Anaplasmosis	C0002797	1	28	8.92929657865e-05	0.0004813466787989081	WDR77
530	Squamous cell carcinoma of the hypopharynx	C0280321	1	28	8.92929657865e-05	0.00048225659690627845	CDK6
531	Abnormality of the anterior pituitary	C4023206	2	181	9.43352934123e-05	0.0004831665150136488	CDKN1A,CDKN1B
532	Cortical gyral simplification	C2749675	1	29	9.58797854748e-05	0.00048407643312101914	CDK6
533	Squamous Cell Neoplasms	C0206720	1	29	9.58797854748e-05	0.0004849863512283895	CCND1
534	Pituitary dependent hypercortisolism	C0221406	1	29	9.58797854748e-05	0.0004858962693357598	CDKN1B
535	Proliferative retinopathy	C0339467	1	29	9.58797854748e-05	0.00048680618744313014	CCND1
536	Oncocytoma, renal	C0346255	1	29	9.58797854748e-05	0.00048771610555050043	CCND1
537	Chromosomal translocation	C0040715	1	29	9.58797854748e-05	0.0004886260236578708	CCND1
538	Secondary hyperparathyroidism	C0020503	2	182	9.58882446735e-05	0.0004895359417652411	CDKN1A,CDKN1B
539	Myocardial Infarction	C0027051	4	1019	9.74244503017e-05	0.0004904458598726114	CDKN1A,E2F1,CCND1,CDKN1B
540	Carcinoid tumor	C0007095	2	183	9.74577378345e-05	0.0004913557779799818	CDKN1A,CDKN1B
541	Laryngeal carcinoma	C0595989	2	184	9.90439915076e-05	0.0004922656960873521	CDKN1A,CCND1
542	Large cell neuroendocrine carcinoma	C1265996	1	30	0.000102698906924	0.0004931756141947225	CCND1
543	Nodular goiter	C1318500	1	30	0.000102698906924	0.0004940855323020928	CCND1
544	Chromophobe Renal Cell Carcinoma	C1266042	1	30	0.000102698906924	0.0004949954504094631	CCND1
545	T-Cell Prolymphocytic Leukemia	C0023494	1	30	0.000102698906924	0.0004959053685168335	CDKN1B
546	Verrucae	C0043037	1	30	0.000102698906924	0.0004968152866242038	CDKN1A
547	Thymic Carcinoma	C1322286	1	30	0.000102698906924	0.0004977252047315742	CCND1
548	Abdominal pain	C0000737	2	187	0.000103903810765	0.0004986351228389445	CDKN1A,CDKN1B
549	Adenocarcinoma of the large intestine	C1319315	2	189	0.000107228823313	0.0004995450409463149	CDKN1A,CCND1
550	Spinal cord compression	C0037926	1	31	0.000109750127468	0.0005004549590536852	CCND1
551	Granuloma	C0018188	1	31	0.000109750127468	0.0005013648771610555	CDKN1A
552	Lichen Sclerosus et Atrophicus	C0023652	1	31	0.000109750127468	0.0005022747952684259	CCND1
553	Well Differentiated Oligodendroglioma	C0751396	2	191	0.000110622623438	0.0005031847133757962	CDKN1B,CDK4
554	Localized skin lesion	C0850826	3	530	0.000111895073474	0.0005040946314831665	CDKN1A,CDKN1B,CDK4
555	Primary cutaneous marginal zone B-cell lymphoma	C0242647	2	193	0.000114085929294	0.0005050045495905369	CCND1,CDKN1B
556	Neoplasms, Second Primary	C0085183	2	193	0.000114085929294	0.0005059144676979072	CDKN1B,CDK4
557	Myeloid leukemia	C0023470	3	533	0.000114359836814	0.0005068243858052776	CDKN1A,CCND1,CDKN1B
558	Cholangitis	C0008311	1	33	0.000124548139703	0.0005077343039126479	CDKN1A
559	Primary Lesion	C1402294	1	33	0.000124548139703	0.0005086442220200183	CCND1
560	Carney complex	C0406810	1	33	0.000124548139703	0.0005095541401273886	CDKN1B
561	Follicular neoplasm	C0474808	1	33	0.000124548139703	0.0005104640582347588	CDK6
562	Hypovolemia	C0546884	1	33	0.000124548139703	0.0005113739763421292	CDKN1A
563	Adenocarcinoma in Situ	C0334276	1	33	0.000124548139703	0.0005122838944494995	PRMT5
564	Adenoid Cystic Carcinoma	C0010606	2	200	0.000126763882241	0.0005131938125568699	CCND1,CDK4
565	Cervix Diseases	C0007867	1	34	0.000132294468251	0.0005141037306642402	CDKN1A
566	Prostate cancer recurrent	C0278838	1	34	0.000132294468251	0.0005150136487716106	E2F1
567	Renal hypertension	C0020544	1	34	0.000132294468251	0.0005159235668789809	CDKN1A
568	Pulmonary Cystic Fibrosis	C0392164	1	34	0.000132294468251	0.0005168334849863512	CDKN1A
569	Comedone	C0221228	1	34	0.000132294468251	0.0005177434030937216	CCND1
570	Inflammatory Myofibroblastic Tumor	C0334121	1	34	0.000132294468251	0.0005186533212010919	CCND1
571	Abnormality of bladder morphology	C0149632	2	205	0.000136360815044	0.0005195632393084623	CDK6,CCND1
572	Burkitt lymphoma	C0006413	2	210	0.00014642008742	0.0005204731574158326	E2F1,CCND1
573	Benign Ovarian Neoplasm	C0004997	1	36	0.000148480934912	0.000521383075523203	CCND1
574	Invasive Lobular Breast Carcinoma	C0279565	1	36	0.000148480934912	0.0005222929936305733	CCND1
575	Hemangioblastoma	C0206734	1	36	0.000148480934912	0.0005232029117379436	CCND1
576	Constitutional symptom	C0009812	3	572	0.00015012911087	0.000524112829845314	CDKN1A,CCND1,CDKN1B
577	Condylomata Acuminata	C0009663	1	37	0.000156920639776	0.0005250227479526843	CDKN1A
578	Costello syndrome	C0587248	1	37	0.000156920639776	0.0005259326660600547	CDK4
579	Chronic viral hepatitis	C0276623	1	37	0.000156920639776	0.000526842584167425	CDKN1A
580	Mammary adenocarcinoma	C3669246	1	37	0.000156920639776	0.0005277525022747954	CCND1
581	Lipoid nephrosis	C0027721	1	37	0.000156920639776	0.0005286624203821657	CDKN1A
582	Rheumatoid arthritis	C0003873	5	1856	0.000158267158428	0.000529572338489536	CDKN1A,CDK6,CCND1,CDKN1B,CDK4
583	Abnormality of digestive system physiology	C4293692	4	1132	0.000160071058817	0.0005304822565969062	CDKN1A,CCND1,CDKN1B,CDK4
584	Liver Diseases	C0023895	3	586	0.000164759272246	0.0005313921747042765	CDKN1A,CDK6,CDK4
585	Mesangiocapillary glomerulonephritis, type II	C0017662	1	38	0.000165590969313	0.0005323020928116469	CDKN1B
586	Abnormal peripheral nervous system morphology	C4025831	3	587	0.000165842503649	0.0005332120109190172	CDKN1A,CCND1,CDKN1B
587	Hepatoblastoma	C0206624	2	220	0.000167965250223	0.0005341219290263876	CCND1,CDKN1B
588	Blast Phase	C0005699	2	221	0.000170226653081	0.0005350318471337579	CDKN1B,CDK4
589	Bulimia nervosa 1	C2267227	1	39	0.000174491894656	0.0005359417652411283	CCND1
590	Anaplastic thyroid carcinoma	C0238461	2	223	0.000174808882998	0.0005368516833484986	E2F1,CCND1
591	Hypopigmentation of the skin	C0162835	2	223	0.000174808882998	0.0005377616014558689	CDKN1A,CDKN1B
592	Metastatic Prostate Carcinoma	C0936223	2	224	0.000177129772812	0.0005386715195632393	CDKN1A,CDKN1B
593	Breast Neoplasms	C1458155	2	225	0.000179470701885	0.0005395814376706096	CCND1,CDK4
594	Symptomatic human immunodeficiency virus infection	C0019693	5	1900	0.000180214902345	0.00054049135577798	CDKN1A,E2F1,CDK6,CCND1,CDKN1B
595	Colorectal Neoplasms	C0009404	4	1164	0.000182483023736	0.0005414012738853503	CDKN1A,CCND1,CDKN1B,CDK4
596	Abnormality of the immune system	C4021753	4	1164	0.000182483023736	0.0005423111919927207	CDKN1A,CCND1,CDKN1B,CDK4
597	Neuropathogenesis	C1518296	1	40	0.00018362301382	0.000543221110100091	E2F1
598	Prolymphocytic Leukemia	C0023486	1	40	0.00018362301382	0.0005441310282074613	CCND1
599	Gastrointestinal dysmotility	C1836923	1	40	0.00018362301382	0.0005450409463148317	CDK4
600	Abnormal gastrointestinal motility	C2749202	1	40	0.00018362301382	0.000545950864422202	CDK4
601	Plague	C0032064	1	40	0.00018362301382	0.0005468607825295724	CCND1
602	Small Lymphocytic Lymphoma	C0855095	1	40	0.00018362301382	0.0005477707006369427	CCND1
603	Stromal sarcoma	C0206630	1	40	0.00018362301382	0.0005486806187443131	CCND1
604	Chronic rejection of renal transplant	C0403592	1	41	0.000192984354031	0.0005495905368516834	CDKN1B
605	Invasive Ductal Breast Carcinoma	C1134719	2	231	0.000193940242188	0.0005505004549590536	CDKN1A,CCND1
606	Hematological neoplasm	C0376545	3	615	0.000198327955337	0.000551410373066424	CDKN1A,CCND1,CDKN1B
607	Erythroblastosis	C0272138	1	42	0.000202575485182	0.0005523202911737943	CCND1
608	Disseminated neuroblastoma	C1135161	1	42	0.000202575485182	0.0005532302092811647	CCND1
609	Malignant Conversion	C1518171	1	42	0.000202575485182	0.000554140127388535	CCND1
610	Unilateral renal agenesis	C0266294	1	42	0.000202575485182	0.0005550500454959054	CDK6
611	Primary malignant neoplasm of brain	C0750979	1	42	0.000202575485182	0.0005559599636032757	CDK4
612	Hypergranular promyelocytic leukemia	C2745900	2	238	0.000211756586597	0.000556869881710646	CDKN1A,CCND1
613	Cholesteatoma	C0008373	1	43	0.000212396404187	0.0005577797998180164	CDKN1A
614	Leukemia, Plasma Cell	C0023484	1	43	0.000212396404187	0.0005586897179253867	CCND1
615	Chronic interstitial cystitis	C0600040	1	43	0.000212396404187	0.0005595996360327571	CDKN1A
616	Anemia	C0002871	3	627	0.000213574984443	0.0005605095541401274	CDKN1A,CCND1,CDKN1B
617	Pain	C0030193	3	628	0.000214882748792	0.0005614194722474978	CDKN1A,CCND1,CDKN1B
618	Pleural Mesothelioma	C0812413	2	240	0.000217035362706	0.0005623293903548681	CDKN1B,CDK4
619	Primary Carcinoma	C1335475	1	44	0.000222446771772	0.0005632393084622384	CCND1
620	Cervical intraepithelial neoplasia grade 1	C0349458	1	44	0.000222446771772	0.0005641492265696088	CCND1
621	Single tumor	C1298180	1	44	0.000222446771772	0.0005650591446769791	CDKN1A
622	Precursor cell lymphoblastic lymphoma	C0079748	1	44	0.000222446771772	0.0005659690627843495	CCND1
623	Monocytic leukemia	C0598894	1	44	0.000222446771772	0.0005668789808917198	CDKN1A
624	Pathologic fracture	C0016663	1	44	0.000222446771772	0.0005677888989990902	CCND1
625	Ocular Hypertension	C0028840	1	44	0.000222446771772	0.0005686988171064605	CDKN1A
626	Abnormality of the biliary system	C0940767	2	243	0.000225112884243	0.0005696087352138308	CDKN1A,CDKN1B
627	Small cell lung cancer	C0149925	3	638	0.000228282988215	0.0005705186533212011	E2F1,CCND1,CDKN1B
628	Ganglioglioma	C0206716	1	45	0.000232726494405	0.0005714285714285714	CDK4
629	Oropharyngeal disorders	C0553694	1	45	0.000232726494405	0.0005723384895359418	CCND1
630	Chondrodysplasia acromesomelic with genital anomalies	C0343284	1	45	0.000232726494405	0.0005732484076433121	CDKN1A
631	Fuchs' Endothelial Dystrophy	C0016781	1	45	0.000232726494405	0.0005741583257506825	CDKN1A
632	Ischemia	C0022116	3	647	0.000240852358446	0.0005750682438580528	CDKN1A,E2F1,CDK4
633	Heterotopia	C0008519	1	46	0.000243235293496	0.0005759781619654231	CDK6
634	CARCINOMA OF VULVA	C0677055	1	46	0.000243235293496	0.0005768880800727935	CCND1
635	Malignant tumor of esophagus	C0546837	3	650	0.000245151453565	0.0005777979981801638	CDKN1A,E2F1,CCND1
636	Lymphoid leukemia	C0023448	2	252	0.000250511297101	0.0005787079162875342	E2F1,CCND1
637	Abnormality of the hypothalamus-pituitary axis	C4025819	2	252	0.000250511297101	0.0005796178343949045	CDKN1A,CDKN1B
638	Germ cell neoplasia	C0205851	2	252	0.000250511297101	0.0005805277525022749	CCND1,CDK4
639	Trisomy 12	C0432408	1	47	0.000253973017877	0.0005814376706096451	CCND1
640	Nijmegen Breakage Syndrome	C0398791	1	47	0.000253973017877	0.0005823475887170154	CDKN1A
641	Spermatogenic failure 3	C1847540	1	47	0.000253973017877	0.0005832575068243858	E2F1
642	Melanocytic nevus of skin	C3665593	1	47	0.000253973017877	0.0005841674249317561	CCND1
643	Li-Fraumeni syndrome	C0085390	1	47	0.000253973017877	0.0005850773430391265	CDKN1A
644	Neck Neoplasms	C0027533	1	48	0.000264939384156	0.0005859872611464968	CCND1
645	Neuronal ceroid lipofuscinosis	C0027877	1	48	0.000264939384156	0.0005868971792538672	COPRS
646	Increased antibody level in blood	C0151669	1	48	0.000264939384156	0.0005878070973612375	CCND1
647	Hyperkeratosis	C0870082	2	258	0.000268435590349	0.0005887170154686078	CCND1,CDK4
648	Senile plaques	C0333463	2	259	0.000271501552274	0.0005896269335759782	TFDP1,CCND1
649	Lymphocytic infiltration	C1262091	1	49	0.000276134306756	0.0005905368516833484	CCND1
650	Coronary Restenosis	C0948480	1	49	0.000276134306756	0.0005914467697907188	CDKN1B
651	Ganglioneuroblastoma	C0206718	1	49	0.000276134306756	0.0005923566878980891	CDKN1A
652	Hepatocellular adenoma	C0206669	1	49	0.000276134306756	0.0005932666060054595	CDKN1B
653	Prostate cancer, familial	C2931456	1	49	0.000276134306756	0.0005941765241128298	CDKN1B
654	Atypical teratoid/rhabdoid tumor	C1266184	1	49	0.000276134306756	0.0005950864422202001	CCND1
655	Papillomavirus Infections	C0950124	1	49	0.000276134306756	0.0005959963603275705	CDKN1A
656	Abnormality of circulating hormone level	C4025652	2	262	0.00028083545664	0.0005969062784349408	CDKN1A,CDKN1B
657	stage, non-small cell lung cancer	C0280217	1	50	0.000287557556067	0.0005978161965423112	CCND1
658	Cerebral Amyloid Angiopathy	C0085220	1	50	0.000287557556067	0.0005987261146496815	CCND1
659	Malignant neoplasm of tongue	C0153349	1	50	0.000287557556067	0.0005996360327570519	CCND1
660	Morphological abnormality of the gastrointestinal tract	C4021073	3	682	0.000294540223307	0.0006005459508644222	CDKN1A,CDKN1B,CDK4
661	Abnormality of digestive system morphology	C4293691	3	682	0.000294540223307	0.0006014558689717925	CDKN1A,CDKN1B,CDK4
662	Uterine Cancer	C0153567	1	51	0.000299208904069	0.0006023657870791629	CCND1
663	Phyllodes tumor, benign	C0010701	1	51	0.000299208904069	0.0006032757051865332	CCND1
664	Ewing's sarcoma	C0553580	2	268	0.000300122666897	0.0006041856232939036	CCND1,CDK4
665	Acute kidney injury	C0022660	2	270	0.000306737374385	0.0006050955414012739	CCND1,CDKN1B
666	Freckling	C0016689	1	52	0.000311088119223	0.0006060054595086443	CDK4
667	Leukoplakia	C0023531	1	52	0.000311088119223	0.0006069153776160146	CDKN1A
668	Neurofibromas	C0027830	1	53	0.000323195118468	0.000607825295723385	CDKN1B
669	Gorlin syndrome	C0004779	1	54	0.000335529529529	0.0006087352138307553	CCND1
670	Abnormality of the pleura	C4025726	1	54	0.000335529529529	0.0006096451319381256	CCND1
671	Low Tension Glaucoma	C0152136	1	54	0.000335529529529	0.0006105550500454959	CDKN1A
672	Tongue Carcinoma	C0558353	1	54	0.000335529529529	0.0006114649681528662	CCND1
673	Abnormal cortical bone morphology	C4021741	1	54	0.000335529529529	0.0006123748862602366	CDK6
674	Endometrial Hyperplasia	C0014173	1	54	0.000335529529529	0.0006132848043676069	CDK4
675	Abnormality of vitamin metabolism	C4022036	1	55	0.000348091379809	0.0006141947224749773	CCND1
676	Bone pain	C0151825	1	56	0.000360880242226	0.0006151046405823476	CCND1
677	Myxoid liposarcoma	C0206634	1	56	0.000360880242226	0.0006160145586897179	CDK4
678	Ganglioneuroma	C0017075	1	56	0.000360880242226	0.0006169244767970883	CCND1
679	Aicardi Goutieres syndrome 1	C0796126	1	56	0.000360880242226	0.0006178343949044586	CCND1
680	Gastric Adenocarcinoma	C0278701	2	286	0.000363080187837	0.000618744313011829	CDKN1A,CCND1
681	Hepatitis C	C0019196	3	721	0.000364017658357	0.0006196542311191993	CDKN1A,E2F1,CDKN1B
682	Malignant Fibrous Histiocytoma	C0334463	1	57	0.000373896090131	0.0006205641492265697	CDK4
683	Endometriosis	C0014175	3	727	0.000375668776277	0.00062147406733394	CDKN1A,CCND1,CDKN1B
684	Hereditary cancer-predisposing syndrome	C0027672	1	58	0.000387138604281	0.0006223839854413103	CDK4
685	Lymphangiomyomatosis	C0751674	1	58	0.000387138604281	0.0006232939035486807	CCND1
686	Chromosome 8, trisomy	C0008671	1	59	0.000400607707398	0.000624203821656051	CCND1
687	cancer recurrence	C0920420	1	59	0.000400607707398	0.0006251137397634214	CCND1
688	Desmoid tumor	C0079218	1	59	0.000400607707398	0.0006260236578707917	CCND1
689	Agenesis of corpus callosum	C0175754	2	301	0.000421616066851	0.0006269335759781621	CDK6,CCND1
690	Primary Glioblastoma	C1514422	1	61	0.000428224608974	0.0006278434940855324	CDK4
691	Adenomatous polyp of colon	C0850572	1	61	0.000428224608974	0.0006287534121929027	CCND1
692	Kidney Diseases	C0022658	3	755	0.000433626658162	0.0006296633303002731	CDKN1A,TFDP2,CCND1
693	Anaplastic carcinoma	C0205696	1	62	0.00044237204078	0.0006305732484076432	CDKN1A
694	Syncope	C0039070	1	62	0.00044237204078	0.0006314831665150136	CDKN1A
695	Childhood Leukemia	C1332977	1	62	0.00044237204078	0.0006323930846223839	CDKN1B
696	gliosarcoma	C0206726	1	64	0.000471343928012	0.0006333030027297543	CDK4
697	Pharyngeal Neoplasms	C0031347	1	64	0.000471343928012	0.0006342129208371246	CDKN1A
698	Ameloblastoma	C0002448	1	65	0.000486167983033	0.0006351228389444949	CCND1
699	Extraosseous Ewings sarcoma-primitive neuroepithelial tumor	C0279980	1	65	0.000486167983033	0.0006360327570518653	CDK4
700	Gonadal neoplasm	C0239763	1	65	0.000486167983033	0.0006369426751592356	CDKN1B
701	Lipoma	C0023798	1	65	0.000486167983033	0.000637852593266606	CDK4
702	Angiogenic Switch	C1510885	1	65	0.000486167983033	0.0006387625113739763	E2F1
703	Pancreatic adenocarcinoma	C0281361	2	320	0.000504080380643	0.0006396724294813467	CDKN1A,CCND1
704	aggressive cancer	C2945759	1	67	0.000516491361014	0.000640582347588717	CDKN1B
705	Occupational Diseases	C0028797	1	68	0.000531990255163	0.0006414922656960873	CDKN1A
706	Hemangiosarcoma	C0018923	1	68	0.000531990255163	0.0006424021838034577	CCND1
707	Histiocytosis, Langerhans-Cell	C0019621	1	68	0.000531990255163	0.000643312101910828	CDKN1A
708	Cholestasis, benign recurrent intrahepatic 1	C0008370	2	328	0.000541688315336	0.0006442220200181984	CDKN1A,CDKN1B
709	Right ventricular hypertrophy	C0162770	1	69	0.000547713662506	0.0006451319381255687	CDKN1A
710	Giant cell tumor of bone	C0206638	1	69	0.000547713662506	0.0006460418562329391	CCND1
711	Lymphocytosis	C0024282	1	69	0.000547713662506	0.0006469517743403094	CCND1
712	Uterine leiomyoma	C0042133	2	331	0.000556243521317	0.0006478616924476797	CDKN1A,CCND1
713	Giant Cell Tumors	C0017525	1	70	0.000563661439161	0.0006487716105550501	CCND1
714	Acromegaly	C0001206	1	70	0.000563661439161	0.0006496815286624204	CDKN1B
715	Nasopharyngeal cancer recurrent	C0153392	1	70	0.000563661439161	0.0006505914467697907	CCND1
716	Juvenile idiopathic arthritis, enthesitis related arthritis	C3495559	2	333	0.000566085399325	0.000651501364877161	TFDP1,CDK6
717	Pulmonary hypertension, neonatal, susceptibility to	C0020542	2	333	0.000566085399325	0.0006524112829845314	CDKN1A,CDKN1B
718	Multiple Endocrine Neoplasia Type 2a	C0025268	1	71	0.000579833384995	0.0006533212010919017	E2F1
719	Retroviridae Infections	C0035369	1	71	0.000579833384995	0.000654231119199272	CCND1
720	Neoplasm of the colon	C0009375	3	817	0.000584497570026	0.0006551410373066424	CDKN1A,E2F1,CCND1
721	Generalized muscle weakness	C0746674	1	72	0.000596229309138	0.0006560509554140127	CCND1
722	Idiopathic Pulmonary Fibrosis	C1800706	2	341	0.000606572610775	0.0006569608735213831	CDKN1A,CCND1
723	Chronic kidney disease	C1561643	2	342	0.000611760514971	0.0006578707916287534	TFDP2,CDKN1B
724	Homocysteinemia due to MTHFR deficiency	C3495426	1	74	0.000629692229907	0.0006587807097361238	CDKN1A
725	Abnormality of nitrogen compound homeostasis	C4025336	1	74	0.000629692229907	0.0006596906278434941	CCND1
726	Granulomatosis with Polyangiitis	C3495801	1	74	0.000629692229907	0.0006606005459508644	CDK6
727	Azotemia	C0242528	1	75	0.000646758832267	0.0006615104640582348	CCND1
